Lene Uhrbom

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Cell death & disease

The Journal of pathology

Nature communications

Glia

This page only lists publications with an associated author ORCID identifier.

Publications

Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell death & disease 15 (4) (2024)
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell death & disease 15 (4) (2024)
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell death & disease 15 (4) (2024)
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell death & disease 15 (4) (2024)
Helene Damhofer, Tülin Tatar, Benjamin Southgate, Scott Scarneo, Karl Agger, Daria Shlyueva, Lene Uhrbom, Gillian M Morrison, Philip F Hughes, Timothy Haystead, Steven M Pollard, Kristian Helin
TAK1 inhibition leads to RIPK1-dependent apoptosis in immune-activated cancers. Cell death & disease 15 (4) (2024)
Xi Lu, Naga Prathyusha Maturi, Malin Jarvius, Irem Yildirim, Yonglong Dang, Linxuan Zhao, Yuan Xie, E-Jean Tan, Pengwei Xing, Rolf Larsson, Mårten Fryknäs, Lene Uhrbom, Xingqi Chen
Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival. Nature communications 13 (1) (2022)
Yuan Xie, Anders Sundström, Naga P Maturi, E-Jean Tan, Voichita D Marinescu, Malin Jarvius, Malin Tirfing, Chuan Jin, Lei Chen, Magnus Essand, Fredrik J Swartling, Sven Nelander, Yiwen Jiang, Lene Uhrbom
LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients. The Journal of pathology 247 (2) (2019)
Naga Prathyusha Maturi, E-Jean Tan, Yuan Xie, Anders Sundström, Tobias Bergström, Yiwen Jiang, Lene Uhrbom
A molecularly distinct subset of glioblastoma requires serum-containing media to establish sustainable bona fide glioblastoma stem cell cultures. Glia 68 (6) (2019)
Matko Čančer, Lisa F Drews, Johan Bengtsson, Sara Bolin, Gabriela Rosén, Bengt Westermark, Sven Nelander, Karin Forsberg-Nilsson, Lene Uhrbom, Holger Weishaupt, Fredrik J Swartling
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells. Cell death & disease 10 (12) (2019)

Lene Uhrbom.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lene Uhrbom